References
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.
- Katagiri R, Iwasaki M, Abe SK, et al. Reproductive factors and endometrial cancer risk among women. JAMA Netw Open. 2023;6(9):e2332296.
- Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9(2):e161–e169.
- Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol. 2024;21(5):389–400.
- Naghavi M, Ong KL, Aali A, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2100–2132.
- Liu Y, Shi W, Mubarik S, Wang F. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: An age period cohort analysis. BMC Public Health. 2024;24(1):1349.
- Yang L, Yuan Y, Zhu R, Zhang X. Time trend of global uterine cancer burden: An age‑period‑cohort analysis from 1990 to 2019 and predictions in a 25‑year period. BMC Womens Health. 2023;23(1):384.
- Ferrari AJ, Santomauro DF, Aali A, et al. Global incidence, prevalence, years lived with disability (YLDs), disability‑adjusted life‑years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133–2161.
- Arbyn M, Anttila A, Jordan J, et al. European guidelines for quality assurance in cervical cancer screening. Second edition—summary document. Ann Oncol. 2010;21(3):448–458.
- Bøje RB, Bardou M, Mensah K, et al. What are the barriers towards cervical cancer screening for vulnerable women?: A qualitative comparative analysis of stakeholder perspectives in seven European countries. BMJ Open. 2024;14(5):e079921.
- Pousette A, Hofmarcher T. Tackling inequalities in cancer care in the European Union. European Federation of Pharmaceutical Industries and Associations. 2024.
- Institute for Health Metrics and Evaluation. Global Burden of Disease Study 2021 (GBD 2021) data resources. Seattle: IHME; 2024.
- Rosenberg PS, Anderson WF. Age‑period‑cohort models in cancer surveillance research: Ready for prime time? Cancer Epidemiol Biomarkers Prev. 2011;20(7):1263–1268.
- Falcaro M, Castañon A, Ndlela B, et al. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: A register‑based observational study. Lancet. 2021;398(10316):2084–2092.
- Zou Z, Cini K, Dong B, et al. Time trends in cardiovascular disease mortality across the BRICS. Circulation. 2020;141(10):790–799.
- Liu Z, Su Z, Li W, et al. Global, regional, and national time trends in disability‑adjusted life years, mortality, and variable risk factors of non‑rheumatic calcified aortic valve disease, 1990–2019: An age‑period‑cohort analysis of the Global Burden of Disease 2019 study. J Thorac Dis. 2023;15(4):2079–2097.
- Su Z, Zou Z, Hay SI, et al. Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age‑period‑cohort analysis for the Global Burden of Disease 2019 study. EClinicalMedicine. 2022;43:101249.
- Rosenberg PS, Check DP, Anderson WF. A web tool for age–period–cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2296–2302.
- Vollset SE, Goren E, Yuan CW, et al. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: A forecasting analysis for the Global Burden of Disease Study. Lancet. 2020;396(10258):1285–1306.
- Møller B, Fekjær H, Hakulinen T, et al. Prediction of cancer incidence in the Nordic countries: Empirical comparison of different approaches. Stat Med. 2003;22(17):2751–2766.
- Ferlay J, Steliarova‑Foucher E, Lortet‑Tieulent J, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–1403.
- Olsen AH, Parkin DM, Sasieni P. Cancer mortality in the United Kingdom: Projections to the year 2025. Br J Cancer. 2008;99(9):1549–1554.
- La Vecchia C, Rota M, Malvezzi M, Negri E. Potential for improvement in cancer management: Reducing mortality in the European Union. Oncologist. 2015;20(5):495–498.
- European Society for Medical Oncology. Death Rates from Ovarian Cancer will Fall in the EU and UK in 2022. Lugano: ESMO; 2022.
- Liontos M, Papatheodoridi A, Andrikopoulou A, et al. Management of the elderly patients with high‑grade serous ovarian cancer in the real‑world setting. Curr Oncol. 2021;28(2):1143–1152.
- Wentzensen N, Poole EM, Trabert B, et al. Ovarian cancer risk factors by histologic subtype: An analysis from the ovarian cancer cohort consortium. J Clin Oncol. 2016;34(24):2888–2898.
- European Union. Population Structure and Ageing. Luxembourg: Publications Office of the European Union; 2025.
- Coburn SB, Bray F, Sherman ME, Trabert B. International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int J Cancer. 2017;140(11):2451–2460.
- Plaxe SC, Braly PS, Freddo JL, McClay E, Kirmani S, Howell SB. Profiles of women age 30‑39 and age less than 30 with epithelial ovarian cancer. Obstet Gynecol. 1993;81(5):651–654.
- Rodriguez M, Nguyen HN, Averette HE, et al. National survey of ovarian carcinoma XII: Epithelial ovarian malignancies in women less than or equal to 25 years of age. Cancer. 1994;73(4):1245–1250.
- Chan JK, Urban R, Cheung MK, et al. Ovarian cancer in younger vs older women: A population‑based analysis. Br J Cancer. 2006;95(10):1314–1320.
- Lim N, Hickey M, Young GP, Macrae FA, Kelly C. Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: A systematic review. Int J Gynecol Cancer. 2022;32(5):646–655.
- European Network of Gynaecological Cancer Advocacy Groups. Ovarian Cancer Factsheet. Brussels: ENGAGe; 2018.
- Mazidimoradi A, Momenimovahed Z, Khalajinia Z, Allahqoli L, Salehiniya H, Alkatout I. The global incidence, mortality, and burden of uterine cancer in 2019 and correlation with SDI, tobacco, dietary risks, and metabolic risk factors: An ecological study. Health Sci Rep. 2024;7(1):e1835.
- Colombo N, Creutzberg C, Amant F, et al. ESMO‑ESGO‑ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow‑up. Ann Oncol. 2016:27(1):16–41.
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
- Rauh‑Hain JA, Pepin KJ, Meyer LA, et al. Management for elderly women with advanced‑stage, high‑grade endometrial cancer. Obstet Gynecol. 2015;126(6):1198–1206.
- Naghavi M, GBD 2021 Italy Subnational Burden of Disease Collaborators. State of health and inequalities among Italian regions from 2000 to 2021: A systematic analysis based on the Global Burden of Disease Study 2021. Lancet Public Health. 2025;10(4):e309–e320.
- Sant M, Minicozzi P, Allemani C, et al. Regional inequalities in cancer care persist in Italy and can influence survival. Cancer Epidemiol. 2012;36(6):541–547.
- Gravdal BH, Lönnberg S, Skare GB, Sulo G, Bjørge T. Cervical cancer in women under 30 years of age in Norway: A population‑based cohort study. BMC Womens Health. 2021;21(1):110.
- Lau H, Juang C, Chen Y, Twu N, Yen M, Chao K. Aggressive characteristics of cervical cancer in young women in Taiwan. Int J Gynaecol Obstet. 2009;107(3):220–223.
- Lancucki L, Fender M, Koukari A, et al. A fall‑off in cervical screening coverage of younger women in developed countries. J Med Screen. 2010;17(2):91–96.
- Wang J, Bai Z, Gao X, Zhang N, Wang Z. The effects of age, period, and cohort on the mortality of cervical cancer in three high‐income countries: Canada, Korea, and Italy. Biomed Res Int. 2021;2021:8829122.
- Cappelli MG, Fortunato F, Tafuri S, et al. Cervical cancer prevention: An Italian scenario between organised screening and human papillomaviruses vaccination. Eur J Cancer Care. 2018;27(5):e12905.
- Calabrò GE, Riccardi MT, D’Ambrosio F, et al. Cervical cancer elimination in Italy: Current scenario and future endeavors for a value based prevention. Front Public Health. 2022;10:1010237.